Overview
The goal of this prospective, waitlist-controlled, 1:1 randomized study is to evaluate if an online mindfulness-based stress reduction (MBSR) intervention reduces treatment-related stress levels among patients with breast cancer receiving chemotherapy.
The main questions it aims to answer are:
- Does an online MBSR intervention reduce stress levels (measured through the Perceived Stress Scale) among participants?
- Does an online MBSR intervention reduce anxiety, depression, insomnia, fatigue, nausea, diarrhea, constipation, pain, and peripheral neuropathy (measured through the PRO-CTCAE of the National Cancer Institute) among participants?
Researchers will compare the online MBSR intervention to no intervention to see if online MBSR reduces treatment-related stress.
Participants will:
- Participate in an online MBSR intervention or no intervention for 6 weeks
- Answer the study surveys at baseline, 7 weeks, and 11 weeks of follow-up
Eligibility
Inclusion Criteria:
- Female sex
- Age ≥18 years
- Diagnosis of non-metastatic breast cancer
- Plan to start neoadjuvant or adjuvant chemotherapy in <4 weeks
- Internet access at home or in their mobile phone
- Availability to participate in the online MBSR intervention for 6 weeks
- Availability to answer the study surveys
- Provision of signed informed consent
Exclusion Criteria:
- Disease recurrence
- Current meditation or mindfulness practice
- Inability to read or write